Capstone Therapeutics Announces Operating Update Conference Call, Planned Initiation Of AEM-28 Phase 1 Study And Fiscal Year 2013 Financial Results
Published: Mar 27, 2014
TEMPE, Ariz., March 27, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), today will hold a conference call and webcast to provide an operating update, discuss the start of AEM-28 Phase 1 clinical studies and report financial results for the fiscal year 2013.
Help employers find you! Check out all the jobs and post your resume.